Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3) > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3):183-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

CASE REPORT   

Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3):183-6

DOI: 10.23736/S0393-3660.20.04466-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

COVID-19 and ST-segment elevation: how far should we go?

Cristina P. CORREIA , Inês A. NEVES, Pedro FERREIRA, Jorge OLIVEIRA

Department of Internal Medicine, São João Hospital Center, Porto, Portugal



Cardiovascular diseases have been associated with higher risk of COVID infection, severity of its clinical presentation and a significant increase in overall mortality. We reported the case of a 77-year-old patient who recovered from a severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2) after a complex treatment approach that included mechanical ventilation for 26 days and high flow nasal cannula (HFNC) therapy for 17 days. Relevant ST-segment elevations in inferior leads were documented, with mild troponin elevation and without relevant ultrasound alterations. A Cardiac magnetic resonance imaging was then requested. We emphasize the relevance of postponing invasive tests until significant recovery. The real incidence of acute myocardial injury related to COVID- 19 requires a standardized definition beyond surveillance of future complications.


KEY WORDS: ST elevation myocardial infarction; SARS-CoV-2; COVID-19

top of page